Upgrade to SI Premium - Free Trial

ARS Pharmaceuticals (SPRY)

4.29 +0.06 (1.42%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (11/17/26)

Latest Headlines

Form 144 ARS Pharmaceuticals, Filed by: Karas Eric October 19, 2026 4:22 PM - SEC Filing Form 4 ARS Pharmaceuticals, For: Oct 01 Filed by: Casale Donn October 5, 2026 4:25 PM - SEC Filing Form 144 ARS Pharmaceuticals, Filed by: Karas Eric October 1, 2026 4:29 PM - SEC Filing Form 144 ARS Pharmaceuticals, Filed by: Karas Eric September 30, 2026 4:30 PM - SEC Filing Form 144 ARS Pharmaceuticals, Filed by: Lowenthal Richard E September 11, 2026 4:19 PM - SEC Filing Form 144 ARS Pharmaceuticals, Filed by: Karas Eric September 11, 2026 4:10 PM - SEC Filing ARS Pharmaceuticals to Participate in Upcoming Investor Conferences September 1, 2026 4:01 PM - StreetInsider Form 144 ARS Pharmaceuticals, Filed by: Lowenthal Richard E August 25, 2026 7:03 PM - SEC Filing Important Notice to Long-Term Shareholders of ARS Pharmaceuticals, Inc. (NASDAQ: SPRY); Hub Group, Inc. (NASDAQ: HUBG); Insulet Corporation (NASDAQ: PODD); and Roblox Corporation (NYSE: RBLX): Grabar August 25, 2026 9:09 AM - StreetInsider Important Notice to Long-Term Shareholders of ARS Pharmaceuticals, Inc. (NASDAQ: SPRY); Roblox Corporation (NYSE: RBLX); Symbotic Inc. (NASDAQ: SYM); and The Simply Good Foods Company (NASDAQ: SMPL): August 24, 2026 8:04 AM - StreetInsider Form 144 ARS Pharmaceuticals, Filed by: Tanimoto Sarina August 20, 2026 5:32 PM - SEC Filing Form 144 ARS Pharmaceuticals, Filed by: Lowenthal Richard E August 20, 2026 4:26 PM - SEC Filing Form 144 ARS Pharmaceuticals, Filed by: Tanimoto Sarina August 19, 2026 4:21 PM - SEC Filing Form 144 ARS Pharmaceuticals, Filed by: Lowenthal Richard E August 19, 2026 4:10 PM - SEC Filing Form 144 ARS Pharmaceuticals, Filed by: Tanimoto Sarina August 18, 2026 6:05 PM - SEC Filing Form 144 ARS Pharmaceuticals, Filed by: Lowenthal Richard E August 18, 2026 5:38 PM - SEC Filing Attention Long-Term Shareholders of ARS Pharmaceuticals, Inc. (NASDAQ: SPRY): Bloom Energy Corporation (NYSE: BE); GPGI, Inc., f/k/a CompoSecure, Inc. (NYSE: GPGI; CMPO); and Insulet Corporation (NASD August 18, 2026 9:10 AM - StreetInsider Form 3 ARS Pharmaceuticals, For: Aug 17 Filed by: Smith Margaret Ekins August 17, 2026 4:45 PM - SEC Filing Attention Long-Term Shareholders of ARS Pharmaceuticals, Inc. (NASDAQ: SPRY); Bloom Energy Corporation (NYSE: BE); Erasca, Inc. (NASDAQ: ERAS); and Insulet Corporation (NASDAQ: PODD): Grabar Law Offic August 14, 2026 9:04 AM - StreetInsider Form 10-Q ARS Pharmaceuticals, For: Jun 30 August 13, 2026 4:08 PM - SEC Filing Form 8-K ARS Pharmaceuticals, For: Aug 13 August 13, 2026 4:03 PM - SEC Filing ARS Pharmaceuticals posts $26.2M in Q2 revenue, cuts ad spending August 13, 2026 4:01 PM - StreetInsider ARS Pharmaceuticals Outlines Strategic Priorities, including a Focused Commercial Strategy, and Reports Second Quarter 2026 Financial Results August 13, 2026 4:01 PM - StreetInsider Grabar Law Office Investigates Claims on Behalf of Long-Term Shareholders of ARS Pharmaceuticals, Inc. (SPRY) August 13, 2026 7:46 AM - StreetInsider ARS Pharmaceuticals Announces Conference Call and Webcast on August 13 Outlining its Updated Strategic Priorities and Reporting Second Quarter 2026 Financial Results August 3, 2026 7:30 AM - StreetInsider Form SCHEDULE 13G ARS Pharmaceuticals, Filed by: BlackRock, Inc. July 27, 2026 4:27 PM - SEC Filing Full Article List